PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Development and application of stability-indicating HPLC method for the determination of nevirapine and its impurity in combination drug product

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A stability-indicating reversed-phase high-performance liquid chromatography method has been developed and validated for the estimation of nevirapine and its impurity, namely the related compound A and the related compound B in combination drug product. The separation was carried out on SUPELCOSIL ABZ (150 mm × 4.6 mm, 5 µm) column. Tablet was admitted to the stress conditions of acid, base, peroxide, thermal, humidity, and photolytic degradation. The degradation products were well resolved from nevirapine, and its impurities peaks and the peak homogeneity of compound were obtained using photo diode array detector, hence proving the stability-indicating nature of the method. Moreover, to prove the selectivity of the method, individual lamivudine, zidovudine, and their main impurities were injected. The developed method was linear for nevirapine from 120 to 360 µg mL-1, and the linear regression obtained was >0.999. Recovery data were in the range 98.2–101.5%. The limit of quantification for related compound A and related compound B was found to be 0.02%. The proposed method was validated according to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use guidelines and proved suitable for stability testing and quality control of these drugs in pharmaceutical preparations.
Słowa kluczowe
Rocznik
Strony
575--587
Opis fizyczny
Bibliogr. 16 poz., rys., tab.
Twórcy
  • Sona College of Technology (Anna University) Department of Sciences Salem 636 005 India
  • Sona College of Technology (Anna University) Department of Sciences Salem 636 005 India
autor
  • Gandhigram Rural Institute (Deemed University) Department of Chemistry Gandhigram 624 302 India
Bibliografia
  • [1] S.C. Sweetman (Ed), Martindale: The Complete Drug Reference, 32nd edn, The Pharmaceutical Press, London, 1996, pp. 622, 623, 630
  • [2] United States Pharmacopeia, United States Pharmacopeia Convention, Rockville, MD, 2008, pp. 2795–2798
  • [3] European Pharmacopoeia, Stationary Office London, 2008, pp. 2495–2496
  • [4] N. Kaul, H. Agarwal, A.R. Paradkar, and K.R. Mahadik, Talanta, 62, 843 (2004)
  • [5] K. Namita, K. Sateesh, and P. Ramesh, Anal. Chimica. Acta., 570, 41 (2006)
  • [6] W. Samee, P. Srilamai, S. Ongart, R. Suwannaratana, Ch. Sornchaithawatwong, and S. Vorarat, J. Thai. Pharm. Health. Sci., 2, 39 (2007)
  • [7] D.A. Kumar, M.V. Naveen Babu, J.V.L.N. Seshagiri Rao, and V. Jajathirtha Rao, RASAYAN. J. Chem., 1, 94 (2010)
  • [8] M. Vogel, N. Betram, J.C. Wasmuth, J. Emmelkamp, J.K. Rockstroh, and C. Reichel, J. Chromatogr. Sci., 48, 91 (2010)
  • [9] O.M.S. Minzi and E. Ngaimisi, J. Chem. Pharm. Res., 2, 431 (2010)
  • [10] C.H.V Kumar, D.A. Kumar, and J.V.L.N. Seshagiri Rao, E-J. Chem. 7, 821 (2010)
  • [11] C. Ghosh, S. Gaur, A. Singh, C.P. Shinde, and B.S. Chakraborty, J. Bioequiv. Availab., 3, 20 (2011)
  • [12] A. Aguiar Castro, R. Queiroz Aucelio, N. Adrian Rey, E. Monsores Miguel, and P. Augusto Mardini Farias, Com. Chem. High T. SCR., 14, 22 (2011)
  • [13] T.V. Sreevidya and B. Narayana, Eclet. Quim., 35, 93 (2010)
  • [14] United States Pharmacopeia, United States Pharmacopeia Convention, Rockville, MD, 2008, pp. 2498–2499
  • [15] United States Pharmacopeia, United States Pharmacopoeia Convention, Rockville, MD, 2008, pp. 3539–3542
  • [16] ICH Guidance on Analytical Method Validation. In: Proc. Int. Convention on Quality for the Pharmaceutical Industry, Toronto, Canada, September 2002
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-6da3e36d-5037-4e4f-b506-69dbe3cad5bd
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.